Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 13, 2012The Journal of Clinical Endocrinology & MetabolismOpen Access

TheBRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study

View Full Paper
Ask AI
Bookmark
Share

Authors

RERossella EliseiUniversity of PisaDVDavid ViolaOspedale VersiliaLTLiborio TorregrossaUniversity of Pisa

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Elisei et al. (2012) studied this question.

synapsesocial.com/papers/6aab3e5fc2d7e755d7bfc0b0https://doi.org/10.1210/jc.2012-1775
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study2008 · 533 citations
  2. 2Clinical Behavior and Outcome of Papillary Thyroid Cancers Smaller than 1.5 cm in Diameter: Study of 299 Cases2004 · 326 citations
  3. 3Increased Incidence of Thyroid Carcinoma in France: A True Epidemic or Thyroid Nodule Management Effects? Report from the French Thyroid Cancer Committee2004 · 385 citations
  4. 4Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce2006 · 2,021 citations
  5. 5The BRAF mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma2006 · 242 citations